Richard Lobo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 25

Top Venues

F1000Research

3 Biotech

Journal of biomolecular structure & dynamics

Journal of toxicology

Manipal University

Manipal College of Pharmaceutical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Manipal University Jun 21 2004

India

ASSOCIATE PROFESSOR :: MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES , DEPT. OF PHARMACOGNOSY

Education History

Manipal College of Pharmaceutical Sciences Dec 30 2004 - May 04 2009

India

PHD :: PHARMACOGNOSY

Publications

Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Ajay Mili, Subham Das, Krishnadas Nandakumar, Richard Lobo
Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study. Journal of biomolecular structure & dynamics (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Abhishek Shah, Aarti Abhishek Shah, Krishnadas Nandakumar, Avinash Kumar, Aravinda Pai, Richard Lobo
In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy. 3 Biotech 11 (9) (2021)
Srinivasa Reddy Jitta, Prasanthi Daram, Karthik Gourishetti, C S Misra, Picheswara Rao Polu, Abhishek Shah, C S Shreedhara, Madhavan Nampoothiri, Richard Lobo
Terminalia tomentosa Bark Ameliorates Inflammation and Arthritis in Carrageenan Induced Inflammatory Model and Freund's Adjuvant-Induced Arthritis Model in Rats. Journal of toxicology 2019 (2019)

Richard Lobo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Lobo